

* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug


(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...


(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...


(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:


* Topps Tiles warns annual profit could drop by 29%


(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.


(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: